Evaluation of Drug Effects on IL-17 and TNF levels in Patients with Rheumatoid Arthritis

Serum levels of tumor necrosis factor alpha and interferon alpha in COVID-19 patients and their correlations with disease severity.

Circulating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity

Interleukin-17: Could it be a key player in COVID-19 infection severity?

Efficacy Of Tocilizumab On Critical Intensive Care Unit COVID-19 Patients: Retrospective Study Among Egyptian Armed Forces Hospitals.

CD177, S100A8 and S100A12 as Markers of Severity in COVID- 19 Patients

Inflammatory changes in Covid19 patients and role of tocilizumab

sIL-2R and sIL-2R/lymphocyte ratio as indicators of severity in COVID-19 pediatric patients

TNF-a and IL-10 Serum Levels in COVID-19 Patients and their Relation to Disease Severity

Association between SARS-CoV-2 seropositivity and disease activity in children with systemic lupus erythematosus